Pulmonary atresia

Jump to navigation Jump to search

For patient information click here

Pulmonary atresia
ICD-10 Q25.5
ICD-9 747.3
MedlinePlus 001091
MeSH C14.240.670

Pulmonary atresia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary atresia from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Labratory findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography or Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Pulmonary atresia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary atresia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary atresia

CDC on Pulmonary atresia

Pulmonary atresia in the news

Blogs on Pulmonary atresia

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pulmonary atresia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Muhammad Waqas

Overview

Pulmonary atresia is a congenital malformation of the pulmonary valve in which the outflow of the blood from the right side of the heart to the pulmonary artery is obstructed due to the valve orifice fails to develop. In most instances, the condition is almost always fatal without any intervention. Atresia means "no opening". In a normal healthy functioning heart, the valve consist of three flaps that opens on ventricular systole leading to emptying of blood from the right ventricle to the pulmonary artery and ultimately to the lungs for proper oxygenation.

This condition often is accompanied by a shunt/foreman ( 'Pulmonary atresia with Ventricular septum defect ) that transports the Oxygen-poor blood directly from the right ventricle to the left side of the heart through a shunt. This oxygen-poor blood is then pumped through the aorta to the rest of the body, making fingers, toes, and lips appear blue or cyanotic. [1] In other instance ( 'Pulmonary atresia with intact Ventricular ventricular septum' ), the blood can not flow from the right side to the left side via shunt and due to this reason, the size of the right ventricle is comparatively smaller than the former one. Early intervention is required in these cases and with the immediate intervention, the 5-year survival is 80 percent.

The type of surgery recommended depends on the size of the right ventricle and the pulmonary artery. If they are normal in size and the right ventricle is able to pump blood, open-heart surgery can be performed to make blood flow through the heart in a normal pattern. If the right ventricle is small and unable to act as a pump, doctors may perform an operation called the Fontan procedure. In this procedure, the right atrium is connected directly to the pulmonary artery. Many children with Pulmonary Atresia will go on to lead 'normal' lives.

Pathophysiology

The pulmonary valve is located on the right side of the heart between the right ventricle and the pulmonary artery. In a normally functioning heart, the opening to the pulmonary valve has three flaps that open and close like one-way doors. As these flaps open and close they force blood to flow forward into the pulmonary artery and backward into the right ventricle then forward again to the lungs where the blood becomes oxygenated. With the disease pulmonary atresia, the flap-like openings are completely covered by a layer of tissue, thus preventing the ability of blood flow to the lungs to become oxygenated. The body requires oxygenated blood for survival.[2] [1] Pulmonary atresia is not threatening to a developing fetus however, because the mother's placenta provides the needed oxygen since the baby's lungs are not yet functional. Once the baby is born its lungs must now provide the oxygen needed for survival, but with Pulmonary atresia, there is no opening on the pulmonary valve for blood to get to the lungs and become oxygenated. Due to this, the newborn baby is blue in color and pulmonary atresia can usually be diagnosed within hours or minutes after birth.

Only an aorta can be seen originating from this pathology specimen. No pulmonary artery is present.

Epidemiology and demographics

  • While there is no difference in the incidence of Pulmonary atresia in male or female, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males than in females. [1]

1) The prevalence of Pulmonary Atresia with VSD is estimated to be around 0.07 per 1000 live breath. and 2.5-3.4 % among all congenital heart diseases.[2]

2) The overall incidence of PA-IVSD is under estimated as most of the fetus are spontaneously aborted due to the underlying other congenital malformations or are diagnosed on routine antenatal ultrasound and results in elective termination.

- The reported incidence is 6-8 per 100,000 live births and 1-3% of all congenital heart disease. [3][4]

Classification

Natural history, Complications, and Prognosis

Causes

Differentiating Pulmonary atresia from other Disorders

As Pulmonic valva atresia presents with the signs and symptoms of right ventricular outflow obstruction, it can be confused with the disease with similar presentation. Diagnosis can be made on the basis of Echocardiographic findings. Conditions sharing the pulmonic outflow obstructions are;

1) Tetralogy of Fallot

2) Critical Pulmonary Stenosis

3) Tricuspid Atresia

Diagnosis

History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical: Medical Therapy

Surgical: Surgery

Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

References

External links


Template:WikiDoc Sources